SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCHINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.999
EU - Europa 2.074
AS - Asia 1.023
SA - Sud America 8
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.973
PL - Polonia 632
CN - Cina 510
RU - Federazione Russa 342
SG - Singapore 292
UA - Ucraina 267
DE - Germania 224
IT - Italia 224
TR - Turchia 165
GB - Regno Unito 152
FI - Finlandia 107
SE - Svezia 33
ID - Indonesia 27
CA - Canada 25
CZ - Repubblica Ceca 25
FR - Francia 17
AT - Austria 15
BE - Belgio 12
LT - Lituania 10
VN - Vietnam 10
IR - Iran 7
BR - Brasile 6
PT - Portogallo 4
IN - India 3
NL - Olanda 3
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
KR - Corea 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
EG - Egitto 1
HK - Hong Kong 1
IE - Irlanda 1
JP - Giappone 1
LB - Libano 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 8.110
Salva come PNG Salva come JPEG
Città #
Fairfield 683
Woodbridge 645
Warsaw 632
Houston 378
Ashburn 373
Chandler 350
Jacksonville 312
Santa Clara 267
Ann Arbor 256
Seattle 256
Singapore 243
Wilmington 243
Cambridge 198
Beijing 142
Nanjing 106
Izmir 102
Ferrara 89
Princeton 71
Munich 69
New York 58
San Diego 56
Shanghai 55
Helsinki 50
Milan 49
Boardman 39
Washington 34
Los Angeles 28
Jakarta 26
Nanchang 25
Hebei 21
Brno 18
Jiaxing 17
Norwalk 16
Shenyang 16
Auburn Hills 14
Vienna 14
Dearborn 13
Falls Church 13
Mcallen 13
London 12
Montréal 12
Tianjin 12
Bremen 11
Brussels 11
Mountain View 11
Bologna 10
Changsha 10
Falkenstein 10
San Mateo 9
Toronto 9
Dong Ket 8
Ningbo 8
Redwood City 8
Ardabil 7
Jinan 7
Kunming 7
Olomouc 7
Zhengzhou 7
Hangzhou 6
Frankfurt am Main 5
Guangzhou 5
Taizhou 5
Arezzo 4
Augusta 4
Philadelphia 4
Phoenix 4
Rome 4
Changchun 3
Ferrara di Monte Baldo 3
Indiana 3
Lanzhou 3
Leawood 3
Monmouth Junction 3
Orange 3
Ottawa 3
Perugia 3
Pieve Emanuele 3
Pisa 3
Redmond 3
Serpa 3
Verona 3
Addison 2
Chiswick 2
Des Moines 2
Hounslow 2
Kilburn 2
Lappeenranta 2
Molinella 2
Nova Friburgo 2
Pescara 2
Pune 2
San Jose 2
Sofia 2
Ancona 1
Auckland 1
Belgrade 1
Blue Ash 1
Cagliari 1
Calderara Di Reno 1
Carros 1
Totale 6.280
Salva come PNG Salva come JPEG
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 452
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 321
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 298
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 273
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 268
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 168
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 147
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 143
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 143
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 134
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 133
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 133
Personalized needles for microinjections in the rodent brain 132
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 130
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 129
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 129
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 128
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 126
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 124
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 124
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 123
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 122
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 120
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 120
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 119
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 119
Involvement of the neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. 117
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 117
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 115
Mechanisms of action of CHF3381 in the forebrain 114
Fibroblast Growth Factor-2 (FGF-2). 113
null 111
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 110
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 109
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 108
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 108
Gene Therapy Tools for Brain Diseases 107
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 97
null 97
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 96
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 96
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 95
null 94
null 94
null 93
Temporal lobe epilepsy model, neural stem cells and gene therapy 93
null 92
null 89
null 89
null 89
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 86
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 78
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 76
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 76
Different patterns of induction of FGF-2 and BDNF mRNAs during kindling epileptogenesis, and development of a herpes simplex vector for FGF-2 gene transfer in vivo. 75
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 75
Implication of sestrin3 in epilepsy and its comorbidities 70
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 69
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 69
Gene therapy of the nervous system by herpes virus vectors 62
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 61
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 48
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 44
null 43
Molecular approaches to inhibit HIV-1 tat expression and functions 41
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 39
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 38
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 37
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 37
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 36
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 35
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 29
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 24
Possible Approaches of Gene Therapy of AIDS. 24
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 23
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 22
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 21
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 20
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 20
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 19
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells 15
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 12
Totale 8.225
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.590
Totale 37.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020809 0 0 0 0 0 0 140 172 137 172 137 51
2020/20211.016 85 115 55 99 53 100 43 113 38 157 113 45
2021/2022742 31 94 61 24 27 28 47 42 20 48 69 251
2022/2023749 75 46 48 80 120 102 39 77 103 4 40 15
2023/2024891 42 46 42 12 50 226 89 97 66 63 50 108
2024/2025880 56 47 154 117 218 268 20 0 0 0 0 0
Totale 8.225